Coronavirus: Moderna says vaccine 100 pct effective against severe COVID-19 cases
US firm Moderna said it would file requests for authorization of its COVID-19 vaccine in the United States and Europe on Monday, after full results confirmed a high efficacy estimated at 94.1 percent.
For more coronavirus news, visit our dedicated page.
The firm said its coronavirus vaccine was 100 percent effective against severe COVID-19 cases in its phase 3 trial.
“Moderna plans today to request EUA (Emergency Use Authorization) from the US FDA (Food and Drug Administration),” Moderna said in a statement, adding it would also “apply for a conditional marketing authorization with the European Medicines Agency (EMA).”
Also Read
-
Coronavirus: UK secures 2 million extra doses of Moderna COVID-19 vaccine
Britain has secured an additional two million doses of Moderna Inc’s COVID-19 vaccine candidate, the government said in a statement on ... Coronavirus -
Coronavirus: EU to sign deal for up to 160 million doses of Moderna COVID-19 vaccine
The European Union will sign a contract for up to 160 million doses of US drugmaker Moderna’s experimental coronavirus vaccine, Ursula von der Leyen, ... Coronavirus -
Coronavirus: Moderna to charge $25-$37 for COVID-19 vaccine, CEO says
Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive ... Coronavirus
